R. Ward

β1 integrin mediates an alternative survival pathway in breast cancer cells resistant to lapatinib

S. Hilsenbeck, R. Schiff, Catherine C. Park, 2011, Breast Cancer Research.

Different mechanisms for resistance to trastuzumab versus lapatinib in HER2- positive breast cancers -- role of estrogen receptor and HER2 reactivation

S. Hilsenbeck, R. Schiff, G. Chamness, 2011, Breast Cancer Research.

Reduced Dose and Intermittent Treatment with Lapatinib and Trastuzumab for Potent Blockade of the HER Pathway in HER2/neu-Overexpressing Breast Tumor Xenografts

S. Hilsenbeck, R. Schiff, G. Arpino, 2011, Clinical Cancer Research.

Hope, optimism and survival in a randomised trial of chemotherapy for metastatic colorectal cancer

M. Stockler, N. Pavlakis, R. Simes, 2015, Supportive Care in Cancer.